SBN sun biomedical limited

effect on us, page-3

  1. gsw
    4,920 Posts.
    Do you remember when the Chairman of SBN, Peter King, put out this statement in May:

    "The sales for the June quarter will be significantly lower due to a general slowdown in purchases by US distributors who have been impacted by the slackening of
    demand for Oraline as the downturn in the US economy is affecting the construction and staffing industries."

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.